Please assess the completion status of the following clinical trial:

Trial Title: Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* T1aN0M0 esophageal cancer (tumor invades no deeper than lamina propria or muscularis mucosa, no regional lymph node or distant metastases), with the following minimum diagnostic workup:~* History/physical exam within 6 weeks prior to enrollment~* PET and CT scan of the chest and abdomen within 12 weeks prior to enrollment~* Endoscopy with histology or cytology confirming carcinoma~* Endoscopic ultrasound (EUS) with evaluation of the esophageal wall, mediastinum, and upper abdomen for evidence of abnormal lymph nodes. Suspicious lymph nodes will undergo EUS-guided fine needle aspiration if appropriate, as determined by the investigator.~* Endoscopic resection of focal lesions with histologic confirmation of positive deep margin or residual cancer within the esophagus~* Not a candidate for or refuses conventional therapies (surgery, radiation, chemotherapy, endoscopic resection) as determined by evaluation by the investigator, discussion with the patient, and review in Thoracic or Gastrointestinal Tumor Board.~* For females: not pregnant (negative pregnancy test within 14 days of starting study treatment), on acceptable means of contraception (oral contraceptives, barrier methods, approved contraceptive implant, long-term injectable contraception, intrauterine device or tubal ligation), or not of child bearing potential. Patients are considered not of child bearing potential if they are surgically sterile (they have undergone a hysterectomy, bilateral tubal ligation, or bilateral oophorectomy) or they are postmenopausal.~* 18 years of age or older~* ECOG Performance Status 0 - 2~Exclusion Criteria:~* Medically unfit or other contraindication to tolerate upper endoscopy with ablation~* Contraindication to endoscopic spray cryotherapy as outlined in the directions for use for the device~* Other malignancy (except nonmelanoma skin cancer) within the past 1 year~* Co-morbid illness expected to cause death within 6 months~* Esophageal stricture preventing passage of endoscope or catheter~* Concurrent enrollment in an investigational drug or device trial that clinically interferes with this study's endpoints throughout the study~* Inability to provide informed consent or comply with this protocol~* Concurrent or previous cancer therapy for current esophageal malignancy by esophagectomy, chemotherapy, radiation therapy, and photodynamic therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cryotherapy (Type: EXPERIMENTAL): Liquid nitrogen spray cryotherapy with the truFreeze device

Based on this trial design, predict the completion outcome and termination type (if applicable).